HUE042691T2 - Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez - Google Patents

Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez

Info

Publication number
HUE042691T2
HUE042691T2 HUE14728622A HUE14728622A HUE042691T2 HU E042691 T2 HUE042691 T2 HU E042691T2 HU E14728622 A HUE14728622 A HU E14728622A HU E14728622 A HUE14728622 A HU E14728622A HU E042691 T2 HUE042691 T2 HU E042691T2
Authority
HU
Hungary
Prior art keywords
thiazolo
pyrimidinone
treatment
inflammatory bowel
bowel diseases
Prior art date
Application number
HUE14728622A
Other languages
English (en)
Hungarian (hu)
Inventor
Chaitanya Dutt
Vijay Chauthaiwale
Ram Gupta
Shitalkumar Zambad
Shailesh Deshpande
Jignesh Kotecha
Ramesh Gupta
Sanjay Srivastava
Laxmikant Chhipa
Jaya Abraham
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of HUE042691T2 publication Critical patent/HUE042691T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
HUE14728622A 2013-05-14 2014-05-12 Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez HUE042691T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1718MU2013 2013-05-14
IN2309MU2013 2013-07-09

Publications (1)

Publication Number Publication Date
HUE042691T2 true HUE042691T2 (hu) 2019-07-29

Family

ID=50896342

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14728622A HUE042691T2 (hu) 2013-05-14 2014-05-12 Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez

Country Status (28)

Country Link
US (2) US9610247B2 (OSRAM)
EP (1) EP2996693B1 (OSRAM)
JP (1) JP6407974B2 (OSRAM)
KR (1) KR102239649B1 (OSRAM)
CN (1) CN105209043B (OSRAM)
AU (1) AU2014266968B2 (OSRAM)
BR (1) BR112015028581B1 (OSRAM)
CA (1) CA2912011C (OSRAM)
CY (1) CY1121280T1 (OSRAM)
DK (1) DK2996693T3 (OSRAM)
EA (1) EA030590B1 (OSRAM)
ES (1) ES2712705T3 (OSRAM)
HR (1) HRP20190315T1 (OSRAM)
HU (1) HUE042691T2 (OSRAM)
IL (1) IL242490B (OSRAM)
LT (1) LT2996693T (OSRAM)
MX (1) MX358198B (OSRAM)
MY (1) MY179215A (OSRAM)
PH (1) PH12015502560B1 (OSRAM)
PL (1) PL2996693T3 (OSRAM)
PT (1) PT2996693T (OSRAM)
RS (1) RS58423B1 (OSRAM)
SG (1) SG11201509275PA (OSRAM)
SI (1) SI2996693T1 (OSRAM)
SM (1) SMT201900111T1 (OSRAM)
TW (1) TWI661828B (OSRAM)
UA (1) UA117244C2 (OSRAM)
WO (1) WO2014184631A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI781922B (zh) * 2016-03-14 2022-11-01 日商參天製藥股份有限公司 由葡甲胺或其鹽構成之防腐劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮
US8541430B2 (en) * 2009-11-27 2013-09-24 Torrent Pharmaceuticals Limited Fused thiazolo and oxazolo pyrimidinones

Also Published As

Publication number Publication date
CN105209043B (zh) 2019-07-02
HRP20190315T1 (hr) 2019-04-05
PL2996693T3 (pl) 2019-05-31
CA2912011A1 (en) 2014-11-20
SG11201509275PA (en) 2015-12-30
AU2014266968A1 (en) 2015-12-03
US20160120801A1 (en) 2016-05-05
SI2996693T1 (sl) 2019-04-30
ES2712705T3 (es) 2019-05-14
PH12015502560A1 (en) 2016-02-22
EP2996693B1 (en) 2018-12-12
IL242490B (en) 2018-11-29
US20170157129A1 (en) 2017-06-08
EA030590B1 (ru) 2018-08-31
AU2014266968B2 (en) 2019-09-19
EA201592159A1 (ru) 2016-04-29
US10471005B2 (en) 2019-11-12
CN105209043A (zh) 2015-12-30
US9610247B2 (en) 2017-04-04
UA117244C2 (uk) 2018-07-10
TW201513866A (zh) 2015-04-16
BR112015028581B1 (pt) 2022-05-03
KR102239649B1 (ko) 2021-04-12
KR20160008571A (ko) 2016-01-22
SMT201900111T1 (it) 2019-02-28
TWI661828B (zh) 2019-06-11
MY179215A (en) 2020-11-02
BR112015028581A2 (pt) 2017-07-25
MX2015015682A (es) 2016-07-20
PH12015502560B1 (en) 2016-02-22
PT2996693T (pt) 2019-02-27
DK2996693T3 (en) 2019-03-18
NZ714098A (en) 2020-12-18
JP6407974B2 (ja) 2018-10-17
LT2996693T (lt) 2019-03-12
CY1121280T1 (el) 2020-05-29
EP2996693A1 (en) 2016-03-23
WO2014184631A1 (en) 2014-11-20
MX358198B (es) 2018-08-08
CA2912011C (en) 2021-10-26
JP2016518440A (ja) 2016-06-23
RS58423B1 (sr) 2019-04-30

Similar Documents

Publication Publication Date Title
IL283943A (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k related disorders
PL3169328T3 (pl) Pochodne chinoliny do leczenia chorób zapalnych
IL243976B (en) kdm1a inhibitors for disease treatment
IL240509B (en) Fluorescence imaging of inflammatory diseases
EP2968208A4 (en) TREATMENT OF CATAPLEXIA
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
LT2981255T (lt) Empagliflozino terapiniai panaudojimo būdai
EP2866826C0 (en) COMBINATION TO TREAT INFLAMMATORY DISORDERS
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
PT3626270T (pt) Tratamento de doenças cardiovasculares
LT3007726T (lt) Tautopatijos gydymo būdai
HRP20181799T1 (hr) Optimizirana farmaceutska formula, namijenjena liječenju upalnih promjena jednjaka
ZA201507718B (en) The local treatment of inflammatory ophthalmic diseases
EP2979720A4 (en) MEDICAL TUBUS
LT3369435T (lt) Kompozicija uždegiminės sąnarių ligos gydymui
EP3046629A4 (en) Treatment of inflammatory skin disease
DK2976101T3 (da) Behandlingsfremgangsmåde
EP3089984A4 (en) NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
IL242490B (en) Use of thiazolopyrimidinone to treat inflammatory bowel disease
DK3041506T3 (da) Behandlingsfremgangsmåde
BR112015003558A2 (pt) aplicador sanitário
PL2870968T3 (pl) Leczenie klinoptilolitem zapalnych chorób jelit
TH1501006822A (th) การใช้ไทอะโซโล ไพริมิดิโนนสำหรับการรักษาโรคลำไส้อักเสบ
GB201321628D0 (en) Treatment of disease
ES1096330Y (es) Dildo desechable